Equities

BlackRock Health Sciences Term Trust

  • Add to watchlist
  • Add to portfolio
  • Add an alert

BlackRock Health Sciences Term Trust

Actions
FinancialsClosed End Investments
  • Price (USD)14.93
  • Today's Change-0.150 / -0.99%
  • Shares traded284.36k
  • 1 Year change-6.92%
  • Beta0.9239
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BlackRock Health Sciences Term Trust (the Trust) is a closed-end management investment trust. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. Trust may also invest in companies of any market capitalization located anywhere in the world, including companies located in emerging markets. The Trust focuses on small and mid-sized healthcare companies. The Trust invests in industries, such as biotechnology, life sciences tools and services, pharmaceuticals, financial services, health care technology, hotels, restaurants and leisure, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.

  • Revenue in USD (TTM)29.84m
  • Net income in USD-68.50m
  • Incorporated2019
  • Employees--
  • Location
    BlackRock Health Sciences Term Trust100 Bellevue ParkwayWILMINGTON 19809United StatesUSA
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
John Hancock Tx dvntgd Dvdnd ncm Fnd-100.00bn-100.00bn888.63m0.00------------------------------------------------------------
Nuveen New York AMT-Fr Qty Mnpl Incm Fd76.70m-77.03m893.29m----0.9939--11.65-0.8831-0.88310.879210.30----------------53.19---100.44----0.34570.4297--------------
Cornerstone Total Return Fund Inc7.68m116.85m894.12m--8.771.15--116.400.86090.86090.05566.540.0087--12.15--13.1612.5113.1712.53-9.1827.991,521.12836.16----0.00173.436.535.47-6.979.19---12.08
Pimco Corporate & Income Strategy Fund84.29m95.13m914.56m--8.821.08--10.851.451.451.2611.820.0973--5.50--10.985.7913.008.0989.6485.57112.8975.59----0.0637134.7225.336.7732.91----0.00
Oppenheimer Holdings Inc1.64bn148.40m915.56m2.98k6.64--11.060.558913.0213.02143.90------------------98.3098.129.036.46--3.44----14.356.45107.393.83--8.45
Calamos Convertible Opprtnts nd Incm Fnd-100.00bn-100.00bn915.72m--------------------------------------------------------------
AllianceBernstein Global Hgh Incm Fd Inc-100.00bn-100.00bn915.76m0.00------------------------------------------------------------
Virtus Investment Partners Inc852.87m138.40m931.70m805.006.87--4.691.0920.0720.07123.54----------------------15.9417.88---------5.967.1513.6811.60--25.56
BlackRock Health Sciences Term Trust29.84m-68.50m933.15m----0.974--31.27-1.06-1.060.376615.330.0206--14.73---4.72---4.74--32.62---229.52----0.10050.00--135.12---66.00------
Blackrock Enhancd Large Cap Core Fnd Inc8.40m117.56m934.98m--7.891.01--111.322.902.900.208122.650.0088--9.67--12.2910.1812.5810.348.2531.511,399.70829.38----0.0065.930.6546-6.95-18.10-5.18--4.36
Ridgepost Capital Inc301.31m15.33m935.13m267.0065.962.7121.673.100.12890.12892.543.140.3361--9.701,128,517.001.972.202.362.65----5.857.95--3.460.497955.9222.6345.86362.169.39177.09--
Gold Royalty Corp14.46m-6.40m953.14m13.00--1.29--65.90-0.0377-0.03770.08493.260.0196--8.761,112,615.00-0.8653---0.8703--71.05---44.27-----0.03010.0834--231.46--87.25------
Calamos Convertible and High Income Fund21.85m185.97m959.50m--5.231.02--43.922.292.290.27311.780.0159--2.22--13.574.8913.674.9249.0734.44851.23377.26----0.3344123.719.45-17.664.05-3.66--3.30
Barings BDC Inc281.87m101.51m960.10m0.009.470.8229--3.410.96380.96382.6811.100.1039--2.92--3.742.943.792.9846.8451.5036.0132.85--6.950.5812120.43-1.0530.49-13.8413.64--14.01
Kayne Anderson BDC Inc230.26m107.19m962.33m0.009.310.861--4.181.511.513.2516.340.1055--30.73--4.91--5.05--51.44--46.55----9.890.5028--32.36--71.18------
Data as of Feb 12 2026. Currency figures normalised to BlackRock Health Sciences Term Trust's reporting currency: US Dollar USD

Institutional shareholders

13.81%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 20251.81m2.89%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Sep 20251.53m2.44%
Penserra Capital Management LLCas of 30 Sep 20251.33m2.13%
UBS Financial Services, Inc.as of 31 Dec 20251.02m1.64%
Invesco Capital Management LLCas of 30 Sep 2025905.77k1.45%
Wells Fargo Clearing Services LLCas of 30 Sep 2025620.20k0.99%
Raymond James & Associates, Inc. (Invt Mgmt)as of 30 Sep 2025415.78k0.67%
Wolverine Asset Management LLCas of 31 Dec 2025401.51k0.64%
RBC Capital Markets LLC (Investment Management)as of 30 Sep 2025331.25k0.53%
Stifel Nicolaus & Co., Inc. (Investment Management)as of 30 Sep 2025266.48k0.43%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.